A Retrospective Data Analysis of Therapy With PRRT Combined With Lanreotide Autogel® for Neuroendocrine Tumours

NCT02788578 · clinicaltrials.gov ↗
TERMINATED
Status
40
Enrollment
INDUSTRY
Sponsor class

Stopped The study terminated prematurely due to insufficient recruitment.

Conditions

Sponsor

Ipsen